SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007–2008. Arthritis Rheum 2011; 63: 313641.
  • 2
    Arromdee E, Michet CJ, Crowson CS, O'Fallon WM, Gabriel SE. Epidemiology of gout: is the incidence rising? J Rheumatol 2002; 29: 24036.
  • 3
    Neogi T, Hunter DJ, Chaisson CE, Allensworth-Davies D, Zhang Y. Frequency and predictors of inappropriate management of recurrent gout attacks in a longitudinal study. J Rheumatol 2006; 33: 1049.
  • 4
    Gutman AB. The past four decades of progress in the knowledge of gout, with an assessment of the present status. Arthritis Rheum 1973; 16: 43145.
  • 5
    Jacob RA, Spinozzi GM, Simon VA, Kelley DS, Prior RL, Hess-Pierce B, et al. Consumption of cherries lowers plasma urate in healthy women. J Nutr 2003; 133: 18269.
  • 6
    Haidari F Jr, Mohammad Shahi M, Keshavarz SA, Rashidi MR. Inhibitory effects of tart cherry (Prunus cerasus) juice on xanthine oxidoreductase activity and its hypouricemic and antioxidant effects on rats. Malays J Nutr 2009; 15: 5364.
  • 7
    Wang H, Nair MG, Strasburg GM, Booren AM, Gray JI. Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod 1999; 62: 868.
  • 8
    Seeram NP, Momin RA, Nair MG, Bourquin LD. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine 2001; 8: 3629.
  • 9
    Kirakosyan A, Seymour EM, Urcuyo-Llanes DE, Kaufman PB, Bolling SF. Chemical profile and antioxidant capacities of tart cherry products. Food Chem 2009; 115: 205.
  • 10
    Kelley DS, Rasooly R, Jacob RA, Kader AA, Mackey BE. Consumption of Bing sweet cherries lowers circulating concentrations of inflammation markers in healthy men and women. J Nutr 2006; 136: 9816.
  • 11
    Schlesinger N, Rabinowitz R, Schlesinger MH. Effect of cherry juice concentration on the secretion of interleukins by human monocytes exposed to monosodium urate crystals in vitro [abstract]. Ann Rheum Dis 2010; 69 Suppl 3: iii610.
  • 12
    He YH, Zhou J, Wang YS, Xiao C, Tong Y, Tang JC, et al. Anti-inflammatory and anti-oxidative effects of cherries on Freund's adjuvant-induced arthritis in rats. Scand J Rheumatol 2006; 35: 3568.
  • 13
    US Food and Drug Administration. List of firms receiving warning letters regarding cherry and other fruit-based products with disease claims in labeling. URL: http://www.fda.gov/Food/GuidanceComplianceRegulatoryInformation/ComplianceEnforcement/ucm081724.htm.
  • 14
    Harrold LR, Mazor KM, Velten S, Ockene IS, Yood RA. Patients and providers view gout differently: a qualitative study. Chronic Illn 2010; 6: 26371.
  • 15
    Zhang Y, Chaisson CE, McAlindon T, Woods R, Hunter DJ, Niu J, et al. The online case-crossover study is a novel approach to study triggers for recurrent disease flares. J Clin Epidemiol 2007; 60: 505.
  • 16
    Mittleman MA, Maclure M, Tofler GH, Sherwood JB, Goldberg RJ, Muller JE, for the Determinants of Myocardial Infarction Onset Study Investigators. Triggering of acute myocardial infarction by heavy physical exertion: protection against triggering by regular exertion. N Engl J Med 1993; 329: 167783.
  • 17
    Wallace SL, Robinson H, Masi AT, Decker JL, McCarty DJ, Yu TF. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum 1977; 20: 895900.
  • 18
    Choi HK, Atkinson K, Karlson EW, Willett W, Curhan G. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004; 350: 1093103.
  • 19
    Terkeltaub RA, Furst DE, Bennett K, Kook KA, Crockett RS, Davis MW. High versus low dosing of oral colchicine for early acute gout flare: twenty-four–hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study. Arthritis Rheum 2010; 62: 10608.
  • 20
    Sundy JS, Baraf HS, Yood RA, Edwards NL, Gutierrez-Urena SR, Treadwell EL, et al. Efficacy and tolerability of pegloticase for the treatment of chronic gout in patients refractory to conventional treatment: two randomized controlled trials. JAMA 2011; 306: 71120.
  • 21
    So A, De Meulemeester M, Pikhlak A, Yucel AE, Richard D, Murphy V, et al. Canakinumab for the treatment of acute flares in difficult-to-treat gouty arthritis: results of a multicenter, phase II, dose-ranging study. Arthritis Rheum 2010; 62: 306476.
  • 22
    Gaffo AL, Schumacher HR Jr, Saag KG, Taylor WJ, Allison J, Chen L, et al. Developing American College of Rheumatology and European League Against Rheumatism criteria for definition of a flare in patients with gout [abstract]. Arthritis Rheum 2009; 60 Suppl: S563.
  • 23
    Van Acker SA, Tromp MN, Haenen GR, van der Vijgh WJ, Bast A. Flavonoids as scavengers of nitric oxide radical. Biochem Biophys Res Commun 1995; 214: 7559.
  • 24
    Huang HY, Appel LJ, Choi MJ, Gelber AC, Charleston J, Norkus EP, et al. The effects of vitamin C supplementation on serum concentrations of uric acid: results of a randomized controlled trial. Arthritis Rheum 2005; 52: 18437.
  • 25
    Choi HK, Gao X, Curhan G. Vitamin C intake and the risk of gout in men: a prospective study. Arch Intern Med 2009; 169: 5027.
  • 26
    Gao X, Curhan G, Forman JP, Ascherio A, Choi HK. Vitamin C intake and serum uric acid concentration in men. J Rheumatol 2008; 35: 18538.
  • 27
    Zhang W, Doherty M, Bardin T, Pascual E, Barskova V, Conaghan P, et al. EULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 131224.
  • 28
    Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol 1991; 133: 14453.
  • 29
    McAlindon T, Formica M, Kabbara K, LaValley M, Lehmer M. Conducting clinical trials over the internet: feasibility study. BMJ 2003; 327: 4847.
  • 30
    Lorig KR, Laurent DD, Deyo RA, Marnell ME, Minor MA, Ritter PL. Can a back pain e-mail discussion group improve health status and lower health care costs? A randomized study. Arch Intern Med 2002; 162: 7926.
  • 31
    Choi HK, Curhan G. Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study. BMJ 2008; 336: 30912.
  • 32
    Choi JW, Ford ES, Gao X, Choi HK. Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59: 10916.